Search Results 1621-1630 of 18740 for Activation

1. Pegfilgrastim-unne (subcutaneous route) - Side effects & dosage - Mayo Clinic

   Do not use the prefilled syringe if the needle guard has been activated. To use the prefilled syringe: Wash your hands with soap and water before and after ...

2. Combination of Serabelisib and Insulin Suppressing Diet in Subjects With Advanced Solid Tumors with PIK3CA Mutations - Mayo Clinic

   Tumor must harbor an activating mutation in the PIK3CA gene with or without PTEN loss, either previously documented or determined during screening. 5. Fresh ...

3. Structure-Function Analyses - Translational Cell Biology of Parkinson's Disease Laboratory - Mayo Clinic Research

   Activation of the E3 ubiquitin ligase Parkin. Biochemical Society Transactions. 2015; doi:10.1042/BST20140321. Siuda J, Jasinska-Myga B, Boczarska-Jedynak M ...

4. A Study to Assess the Safety and Tolerability of CFT8634 in Locally Advanced or Metastatic SMARCB1-Perturbed Cancers, Including Synovial Sarcoma and SMARCB1-Null Tumors - Mayo Clinic

   Coagulation: Prothrombin time (PT)/international normalized ratio (INR) < 1.5 x the upper limit of normal (ULN) and activated partial thromboplastin time ...

5. Understanding Immune System Health

   The inflammatory response activates a cascade of immune reactions that ... This is a sign that the immune system has been activated and is sending ...

6. Study to Compare the Safety and Effectiveness of Treatment Combinations in Patients with Recurrent Ovarian Cancer - Mayo Clinic

   Activated partial thromboplastin time ≤ 1.5 × ULN unless patient is receiving anticoagulant therapy as long as PT or PTT is within therapeutic range of ...

7. Azacitidine and Sonidegib in Treating Patients With Myeloid Malignancies - Mayo Clinic

   Inappropriate activation of Hh pathway signaling and uncontrolled cellular proliferation may be associated with mutations in the Hh-ligand cell surface receptor ...

8. Pemigatinib to Treat Metastatic or Unresectable Colorectal Cancer Harboring FGFR Alterations - Mayo Clinic

   Documentation of an activating genomic alteration(s) in FGF/FGFR1-3 (gain of function mutations, translocations, and amplifications allowed) in tumor tissue ...

9. Clinical trials - Oncology (Medical)

   Fibroblast activation protein (FAP) is a cell surface protein that is highly expressed on the surface of cancer-associated fibroblasts (CAFs) present in the ...

10. CD19-Directed CAR-T Cell Therapy for the Treatment of Relapsed/​Refractory B Cell Malignancies - Mayo Clinic

    ... activated partial thromboplastin time (aPTT) =\< 1.5 x ULN OR if patient is receiving anticoagulant therapy and INR or aPTT is within target range of ...